Literature DB >> 1168690

Humoral immunostimulation. IV. Role of complement.

W T Shearer, J P Atkinson, M M Frank, C W Parker.   

Abstract

When L cells were treated with anti-L-cell antibody in medium containing heat-inactivated fetal calf serum, nucleoside uptake and cell growth were stimulated. The response was markedly increased when fresh, unheated sera from calves, guinea pigs, humans, mice, or rabbits were also present. The factors in unheated serum responsible for the enhancement of immunostimulation were studied. Using low concentrations of sera deficient in various complement (C) components and low concentrations of antibody no augmentation of immunostimulation was seen with Clr-deficient human serum, C2-deficient human serum, C2,4-deficient human serum, C4-deficient guinea pig serum, C3-C9-depleted guinea pig serum (by administration of cobra venom factor to animals), but stimulation was observed with C5-deficient human serum, C5-deficient mouse serum, and C6-deficient rabbit serum. When the concentration of anti-serum was raised, however, augmentation was observed with C4-deficient guinea pig serum. Thus, at low concentrations of antiserum enhancement appeared to occur through the classical C pathway, whereas at high concentrations of antibody either the classical or alternate C pathways appeared to be involved. Stimulation was specifically restored by purified C2 in C2-deficient serum and by C3 in C3-C9-deficient serum. Under the usual reaction conditions consumption of guinea pig C component C4 could be demonstrated which provided direct evidence for activation of the classical C pathway under conditions leading to immunostimulation. By immunofluorescence, cells treated with antibody and normal human serum had human C3 deposited at the cell surface. Taken together these observations suggest that C activated through C3 by either the classical or alternate pathways has the potential to enhance nucleoside incorporation into DNA and cell growth of cells exposed to limiting amounts of antibody. Although the mechanism of stimulation is unknown, it is likely to involve a direct effect of C3 at the level of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168690      PMCID: PMC2189750     

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

2.  Hypothesis. Bound C3 as the second signal for B-cell activation.

Authors:  P Dukor; K U Hartmann
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

3.  A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway.

Authors:  J E May; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

Review 4.  The complement system of man. I.

Authors:  S Ruddy; I Gigli; K F Austen
Journal:  N Engl J Med       Date:  1972-09-07       Impact factor: 91.245

5.  Involvement of proteolytic acivity in early events in lymphocyte transformation by phytohemagglutinin.

Authors:  M Saito; T Yoshizawa; T Aoyagi; Y Nagai
Journal:  Biochem Biophys Res Commun       Date:  1973-05-15       Impact factor: 3.575

6.  Stimulation of cells by antibody.

Authors:  W T Shearer; G W Philpott; C W Parker
Journal:  Science       Date:  1973-12-28       Impact factor: 47.728

7.  Deficiency of the sixth component of complement in rabbits with an inherited complement defect.

Authors:  K Rother; U Rother; H J Müller-Eberhard; J R Nilsson
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

8.  Humoral immunostimulation. I. Increased uptake of (125I)iododeoxyuridine and (3H)thymidine into TNP-cells treated with anti-TNP antibody.

Authors:  W T Shearer; G W Philpott; C W Parker
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

9.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.

Authors:  A N Theofilopoulos; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  6 in total

1.  Incorporation of fatty acids into phospholipids in L cells stimulated by antibody.

Authors:  W T Shearer; R G Ulrich
Journal:  Lipids       Date:  1984-04       Impact factor: 1.880

2.  Antibody-independent complement activation by a subpopulation of mitogen-induced human T lymphoblasts.

Authors:  M J Martin; J Vega; C Gutiérrez
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

Review 3.  Synthesis of lipids or lipid-containing macromolecules in tumor cells. Relevance to host defense.

Authors:  S H Ohanian
Journal:  Surv Immunol Res       Date:  1983

4.  Humoral immunostimulation. V. Selection of variant cell lines.

Authors:  W T Shearer; C W Parker
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

Review 5.  Complement inhibition in cancer therapy.

Authors:  Ruben Pio; Daniel Ajona; John D Lambris
Journal:  Semin Immunol       Date:  2013-05-24       Impact factor: 10.671

6.  Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.

Authors:  H Molina; W Wong; T Kinoshita; C Brenner; S Foley; V M Holers
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.